Why is "Entactogen" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-13 19:55:04
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Entactogens, also known as empathogens or connectogens, are a class of psychoactive drugs that induce experiences of emotional communion, oneness, connectedness, emotional openness—that is, empathy—as particularly observed and reported for experiences with MDMA (ecstasy). This class of drug is distinguished from the classes of hallucinogens or psychedelics and stimulants, although entactogens, for instance MDMA, can also have these properties. Entactogens are used both as recreational drugs and are being investigated for medical use in the treatment of psychiatric disorders, for instance MDMA-assisted therapy for post-traumatic stress disorder (PTSD).
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated - Frontiers
-
Therapeutic mechanisms of psychedelics and entactogens - Neuropsychopharmacology - Nature
-
Entactogen Effects of Ketamine: A Reverse-Translational Study - Psychiatry Online
-
Finding Solutions When Depression Resists Treatment - Columbia University Department of Psychiatry
-
Ketamine as an entactogen: Scientists reveal intriguing impact on social pleasure and empathy - PsyPost
-
Modulation of Social Cognition via Hallucinogens and “Entactogens” - Frontiers
-
Psychoactive Drugs Are Having a Moment. The FDA Will Soon Weigh In. - California Healthline
-
Ketamine, the First Associative Anesthetic? Some Considerations on Classifying Psychedelics, Entactogens, and Dissociatives - Psychiatry Online
-
Transcend's neuroplastogen posts positive mid-stage results in PTSD - FirstWord Pharma
-
Psychedelic, empathogen, connectogen — how do we classify MDMA? 5 Questions for neuroscientist Matt Baggott - The Microdose | Substack
-
From 'party drug' to PTSD treatment: ATAI launches EmpathBio to develop MDMA-based therapy - Fierce Biotech
-
ATAI Life Sciences Launches EmpathBio with Focus on PTSD Treatment - BioSpace
-
Atai Life Sciences launches Phase 1 clinical trial of MDMA derivative - drugdiscoverytrends.com
-
Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG | Neuropsychopharmacology - Nature
-
Poppin’ up everywhere - Daily Bruin
-
This Week in Psychedelics: “Candyflipping,” a non-hallucinogenic LSD, and reconsidering “treatment-resistant depression” - The Microdose | Substack
-
MDMA can help treat PTSD, yet another study shows - Boing Boing
-
Forensic Detection of Narcotic Drugs -II: LSD-Drug of The Young - Mangalore Today
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.